Analysis of the differential proteome of human erythroblasts during in vitro erythropoiesis by 2-D DIGE

Proteomics - Clinical Applications

Volumn 3, Issue 9, 2009, Pages 1123-1134

  Richardson, Ben M ^a   Heesom, Kate J ^a   Parsons, Steve F ^b   Anstee, Dave J ^b   Frayne, Jan ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

2 D DIGE; 2 D PAGE; Erythropoiesis

Indexed keywords

CARBONATE DEHYDRATASE I; LIPOCORTIN 1; LIPOCORTIN 2; PROTEOME;

ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DIFFERENTIAL IN GEL ELECTROPHORESIS; ERYTHROBLAST; ERYTHROPOIESIS; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; WESTERN BLOTTING;

EID: 70350765300     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200900013     Document Type: Article

References (47)

1. Oki, M., Ando, K., [Hematopoietic growth factors, cytokines, and bone-marrow microenvironment]. Nippon rinsho 2008, 66, 444-452.
2. Whetton, A. D., Spooncer, E., Role of cytokines and extracellular matrix in the regulation of haemopoietic stem cells. Curr. Opin. Cell Biol. 1998, 10, 721-726.
3. Kim, S. I., Bresnick, E. H., Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene 2007, 26, 6777-6794.
4. Telen, M. J., Erythrocyte adhesion receptors: blood group antigens and related molecules. Transfus. Med. Rev. 2005, 19, 32-44.
5. Dai, C. H., Krantz, S. B., Zsebo, K. M., Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 1991, 78, 2493-2497.
6. Muta, K., Krantz, S. B., Bondurant, M. C., Dai, C. H., Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995, 86, 572-580.
7. Southcott, M. J., Tanner, M. J., Anstee, D. J., The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999, 93, 4425-4435.
8. Gregory, C. J., Eaves, A. C., Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood 1977, 49, 855-864.
9. Gregory, C. J., Eaves, A. C., Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 1978, 51, 527-537.
10. Iscove, N. N., The role of erythropoietin in regulation of population size and cell cycling of early and late erythroid precursors in mouse bone marrow. Cell Tissue Kinet. 1977, 10, 323-334.
11. Wang, J., Tang, Z. Y., Ka, W., Sun, D. et al., Synergistic effect of cytokines EPO, IL-3 and SCF on the proliferation, differentiation and apoptosis of erythroid progenitor cells. Clin. Hemorheol. Microcirc. 2007, 37, 291-299.
12. Bony, V., Gane, P., Bailly, P., Cartron, J. P., Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br. J. Haematol. 1999, 107, 263-274.
13. Kie, J. H., Jung, Y. J., Woo, S. Y., Ryu, K. H. et al., Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34+cells. Ann. Hematol. 2003, 82, 278-283.
14. Papayannopoulou, T., Brice, M., Integrin expression profiles during erythroid differentiation. Blood 1992, 79, 1686-1694.
15. Bellantuono, I., Haemopoietic stem cells. The Int. J. Biochem. Cell Biol. 2004, 36, 607-620.
16. Morrison, S. J., Wandycz, A. M., Hemmati, H. D., Wright, D. E., Weissman, I. L., Identification of a lineage of multipotent hematopoietic progenitors. Development 1997, 124, 1929-1939.
17. Komor, M., Guller, S., Baldus, C. D., de Vos, S. et al., Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation. Stem cells 2005, 23, 1154-1169.
18. Singleton, B. K., Burton, N. M., Green, C., Brady, R. L., Anstee, D. J., Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008, 112, 2081-2088.
19. Jensen, O. N., Interpreting the protein language using proteomics. Nat. Rev. 2006, 7, 391-403.
20. Zenzmaier, C., Gesslbauer, B., Grobuschek, N., Jandrositz, A. et al., Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem. Biophys. Res. Commun. 2005, 328, 968-972.
21. Low, T. Y., Seow, T. K., Chung, M. C., Separation of human erythrocyte membrane associated proteins with onedimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002, 2, 1229-1239.
22. Pasini, E. M., Kirkegaard, M., Mortensen, P., Lutz, H. U. et al., In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006, 108, 791-801.
23. Kakhniashvili, D. G., Griko, N. B., Bulla L. A., JR., Goodman, S. R., The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp. Biol. Med. (Maywood) 2005, 230, 787-792.
24. Fricke, B., Parsons, S. F., Knopfle, G., von During, M., Stewart, G. W., Stomatin is mis-trafficked in the erythrocytes of overhydrated hereditary stomatocytosis, and is absent from normal primitive yolk sac-derived erythrocytes. Br. J. Haematol. 2005, 131, 265-277.
25. Voss, T., Haberl, P., Observations on the reproducibility and matching efficiency of two-dimensional electrophoresis gels: consequences for comprehensive data analysis. Electrophoresis 2000, 21, 3345-3350.
26. He, K. L., Deora, A. B., Xiong, H., Ling, Q. et al., Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J. Biol. Chem. 2008, 283, 19192-19200.
27. Gilmore, W. S., Olwill, S., McGlynn, H., Alexander, H. D., Annexin A2 expression during cellular differentiation in myeloid cell lines. Biochem. Soc. Trans. 2004, 32, 1122-1123.
28. Bianchi Scarra, G. L., Romani, M., Coviello, D. A., Garre, C. et al., Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Cancer Res. 1986, 46, 6327-6332.
29. Chiang, Y., Rizzino, A., Sibenaller, Z. A., Wold, M. S., Vishwanatha, J. K., Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol. Cell. Biochem. 1999, 199, 139-147.
30. Leder, A., Orkin, S., Leder, P., Differentiation of erythroleukemic cells in the presence of inhibitors of DNA synthesis. Science 1975, 190, 893-894.
31. Lim, L. H., Pervaiz, S., Annexin 1: the new face of an old molecule. FASEB J. 2007, 21, 968-975.
32. Shalloe, F., Elliott, G., Ennis, O., Mantle, T. J., Evidence that biliverdin-IX beta reductase and flavin reductase are identical. Biochem. J. 1996, 316, 385-387.
33. Yamaguchi, T., Komoda, Y., Nakajima, H., Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from human liver. Purification and characterization. J. Biol. Chem. 1994, 269, 24343-24348.
34. Mack, C. P., Hultquist, D. E., Shlafer, M., Myocardial flavin reductase and riboflavin: a potential role in decreasing reoxygenation injury. Biochem. Biophys. Res. Commun. 1995, 212, 35-40.
35. Dailey, H. A., Terminal steps of haem biosynthesis. Biochem. Soc. Trans. 2002, 30, 590-595.
36. Kohno, H., Furukawa, T., Yoshinaga, T., Tokunaga, R., Taketani, S., Coproporphyrinogen oxidase. Purification, molecular cloning, and induction of mRNA during erythroid differentiation. J. Biol. Chem. 1993, 268, 21359-21363.
37. Ponka, P., Sheftel, A. D., Zhang, A. S., Iron targeting to mitochondria in erythroid cells. Biochem. Soc. Trans. 2002, 30, 735-738.
38. Woo, H. A., Jeong,W., Chang, T. S., Park, K. J. et al., Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J. Biol. Chem. 2005, 280, 3125-3128.
39. Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U. et al., Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005, 435, 347-353.
40. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
41. Sly, W. S., Hu, P. Y., Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 1995, 64, 375-401.
42. Kondo, T., Sakai, M., Isobe, H., Taniguchi, N. et al., Induction of carbonic anhydrase I isozyme precedes the globin synthesis during erythropoiesis in K562 cells. Am. J. Hematol. 1991, 38, 201-206.
43. Chen, J., Kremer, C. S., Bender, T. P., The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Oncogene 2006, 25, 2758-2772.
44. Rabilloud, T., Heller, M., Gasnier, F., Luche, S. et al., Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002, 277, 19396-19401.
45. Rhee, S. G., Chae, H. Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38, 1543-1552.
46. Karp, N. A., Kreil, D. P., Lilley, K. S., Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4, 1421-1432.
47. Giarratana, M. C., Kobari, L., Lapillonne, H., Chalmers, D. et al., Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat. Biotechnol. 2005, 23, 69-74.